SPECIAL NOTICE
66 -- Maintenance - FDANOI1207761
- Notice Date
- 11/8/2018
- Notice Type
- Special Notice
- NAICS
- 811219
— Other Electronic and Precision Equipment Repair and Maintenance
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDANOI1207761
- Point of Contact
- Telisha Wilson, Phone: 2404027572
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Maintenance PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT INTENDED SOURCE: JOEL USA, Inc. ANTICIPATED PERIOD of PERFORMANCE: 11/16/2018-11/15/2019 DESCRIPTION OF REQUIREMENT: Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 13.501(a)(1)(ii), the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to JOEL USA, Inc. to include a base period of one (1) year and four (4) one (1) year option periods. JEOL USA, Inc. is the only manufacturer that can service the JEM-1011 TRANSMISSION ELECTRON MICROSCOPE with warranty-specific, guaranteed JEOL parts. JEOL USA, Inc. is the sole manufacturer of the JEM-1011 Transmission Electron Microscope and the only source that can provide the equipment. The FDA has a critical need for a facility and instrumentation capable of studying the ultrastructure of mammalian and microbial specimens with special emphasis on pathological consequences. The applicable North American Industry Classification System (NAICS) code for this acquisition 334516, Analytical Laboratory Instrument Manufacturing. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities shall be submitted in writing and shall contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. All interested parties shall express their interest and capabilities in writing via email to Telisha.Wilson@fda.hhs.gov within seven (7) days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within fifteen (15) days, an award will subsequently be made to JOEL USA, Inc. This is a Federal contract opportunity; FDA-NOI-1207761 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD. Response Due NLT 10:00 AM 11/14/2018 Set-Aside No Set-Aside Used Contact(s) Telisha Wilson Agency Department of Health and Human Services Office Food and Drug Administration Location Office of Acquisitions and Grants Services - Rockville
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDANOI1207761/listing.html)
- Record
- SN05147580-W 20181110/181108230834-c71d1c9cb86ad6b6e0ac391c4b60f5dd (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |